Drug Profile
Research programme: PPAR gamma agonists - Vita
Alternative Names: PPAR gamma receptor agonists research programme - Vita; VDO 52Latest Information Update: 08 May 2008
Price :
$50
*
At a glance
- Originator Vita
- Class Thiazolidinediones
- Mechanism of Action Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 03 Sep 2004 Grupo Vita has been acquired by Procter & Gamble
- 03 Sep 2004 Grupo Vita is now called Vita
- 19 Sep 2002 Preclinical trials in Type-2 diabetes mellitus in Spain (unspecified route)